“Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute Myocardial Infarction and Heart Failure Paul A Heidenreich,

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights reserved. Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute.
Advertisements

© 2010, American Heart Association. All rights reserved. Are Quality Improvements Associated with the GWTG-Coronary Artery Disease (GWTG-CAD) Program Sustained.
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction Robert W. Yeh, MD MSc Massachusetts General Hospital Alan S. Go, MD Kaiser.
Does pay for performance save lives? Martin Roland University of Cambridge UK.
“Influence of Stroke Subtype on Quality of Care in The Get With The Guidelines-Stroke Program” Eric E. Smith, MD, MPH; Li Liang PhD; Adrian F Hernandez,
Introduction to Core Measures Lynn Benson Preferred Nurse Staffing.
Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly Findings From the Get With the Guidelines Quality-
Cohen et al. Circulation. ePub May 17, 2010 Racial and Ethnic Differences in the Treatment of Acute Myocardial Infarction Findings From Get With The Guidelines.
Regional Differences in Quality of Care and Outcomes for the Treatment of Acute Coronary Syndromes: An Analysis from the Get With The Guidelines Program.
CMS Core Measures Evidence-Based Performance Measurement.
0 Hospital Quality Incentive Demonstration (HQID) Key Facts Three year demo ( ); extended for three additional years through Oct hospitals.
The Relationship Between CMS Quality Indicators and Long-term Outcomes Among Hospitalized Heart Failure Patients Mark Patterson, Ph.D., M.P.H. Post-doctoral.
“Influence of age on the management of heart failure: Findings from Get With the Guidelines–Heart Failure (GWTG-HF)” Daniel E. Forman, MD; Christopher.
MIRACL, Val-HeFT, Cheney Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director of the Joseph J Jacobs Center.
Are Quality Improvements Associated with the GWTG-Coronary Artery Disease (GWTG-CAD) Program Sustained Over Time? A Longitudinal Comparison of GWTG-CAD.
“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,
RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.
Quality of Care and In-Hospital Outcomes in Patients With Coronary Heart Disease in Rural and Urban Hospitals (from Get With the Guidelines– Coronary.
Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure Adrian F. Hernandez, MD, MHS; Gregg.
CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative Purpose To determine whether the angiotensin.
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
EHR for Meaningful Use Clinical Quality Measures Dr. Aneel Advani Associate Director for Informatics IHS Office of Information Technology Indian Health.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Health Care Effectiveness Summer Quarterly Meeting July 19, 2011.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Schwamm et al. Circulation epub April 6Schwamm et al. Race/Ethnicity, Quality of Care, and Outcomes in Ischemic Stroke Lee H. Schwamm, MD; Mathew.
ACUTE MYOCARDIAL INFARCTION Team Membership Clinical Departments: Cardiology, Cardiovascular Surgery, Emergency Medical Services Hospital Departments:
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
” “The Dissociation Between Door-to- Balloon Time Improvement and Improvements in Other Acute Myocardial Infarction Care Processes and Patient Outcomes”
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
Introduction to Core Measures
Surgical Care FMHGettysburgShady Grove Mont.Gen.CHCWCHS 86% of 383 pts. 90% of 337 pts 86% of 254 pts 93% of 323 pts 78% of 301 pts 93% of 874 pts Percent.
Acute Myocardial Infarction (Heart Attack) Committee Membership: B. Majcher, APRN, C. Mulhall, APRN, K. McLean, MD, M. Jarotkiewicz RRT, MS, Administrative.
Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.
1 Hospital P4P: The CMS/Premier Hospital Quality Incentive Demonstration Project March 10, 2009 Mary B. Bergerson Regional Quality Director St. Helena.
Component 2: The Culture of Health Care Unit 7: Quality Measurement, Performance Improvement, and Incentive Payment Schemes Lecture 4 This material was.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
Quality Measurement and Improvement Component 2 / Unit 7d.
Review of an article Not all Angiotension-Converting Enzyme (ACE) inhibitors are Equal: Focus on Ramipril and Perindopril DiNicolantonio J, Lavie C, O’Keefe.
Assessing Inpatient Care Using Hospital Quality Alliance Patient Level Quality Data What can we learn about inpatient care quality from patient-level data.
Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? Pamela N. Peterson, MD MSPH; John S. Rumsfeld, MD PhD; Li Liang PhD; Adrian F. Hernandez,
Acute Myocardial Infarction (Heart Attack) Committee Membership: B. Majcher, APRN, C. Mulhall, APRN, K. McLean, MD, M. Jarotkiewicz MBA, M. Morrow, RN,
Wins/Losses and Errors/Ties: Quality of Care for Acute Myocardial Infarction in the VA Health Care System Laura A. Petersen, M.D., M.P.H. 1 Sharon-Lise.
Safer Healthcare Now! Acute Myocardial Infarction Presented by Amanda Thompson, Safer Healthcare Now Facilitator.
Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial PEACE Trial Presented at The American Heart Association Scientific Sessions.
Changes in racial disparities under public reporting and pay for performance Rachel M. Werner.
Which Beta-Blocker is Best for Patients with Heart Failure? Summary and Comment by Joel M. Gore, MD Published in Journal Watch Cardiology December 17,
HEART FAILURE Team Membership Clinical Departments: Cardiology, Cardiovascular Surgery, Nursing, QRM, CCE, Medical Records Project Coordinators: Carmen.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Association of Guideline-Based Admission Treatments.
HEART FAILURE TEAM MEMBERSHIP DEPARTMENTS OF CARDIOLOGY, CARDIOVASCULAR SURGERY, MEDICINE, NURSING, QUALITY AND RESOURCE MANAGEMENT, THE CENTER FOR CLINICAL.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
A Statewide Collaborative Initiative to Improve the Quality of Care for Patients With Acute Myocardial Infarction and Heart Failure Circulation. 2009;119:
The Department of Quality and Risk Management
Total Occlusion Study of Canada (TOSCA-2) Trial
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
1000 Lives Plus: National Learning Event
Copyright © 2007 American Medical Association. All rights reserved.
Jeff Macemon Waikato Cardiothoracic Unit
Patterns of Use of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Among Patients With Acute Myocardial Infarction in China From.
Information provided by: Yvette Mansion-Whittaker
National Quality Assessment Evaluating Spironolactone Use During Hospitalization for Acute Myocardial Infarction (AMI) in China: China Patient-centered.
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Global Registry of Acute Coronary Events: GRACE
Information provided by: Yvette Mansion-Whittaker
Cardiovascular Epidemiology and Epidemiological Modelling
Many post-MI patients are not receiving optimal therapy
Presentation transcript:

“Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute Myocardial Infarction and Heart Failure Paul A Heidenreich, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA; William R Lewis, MetroHealth Campus, Case Western Reserve University, Cleveland, OH; Kenneth A LaBresh, RTI International, Waltham, MA; Lee H Schwamm, Massachusetts General Hospital, Boston, MA; Gregg C Fonarow, Ahmanson-UCLA Cardiomyopathy Medical Center; Heidenreich PA et al. Circulation 2009

Background Many hospitals enrolled in the American Heart Association’s Get With The Guidelines (GWTG) Program achieve high levels of recommended care for heart failure, acute myocardial infarction and stroke. However, it is unclear if outcomes are better in those hospitals recognized by the GWTG program for their processes of care. Heidenreich PA et al. Circulation 2009

Introduction Get With The Guidelines (GWTG) is a national performance improvement initiative of the American Heart Association (AHA) to improve guidelines adherence in patients hospitalized with CAD, HF and Stroke. Hospitals enrolled in the GWTG program have demonstrated better process of care than other hospitals for acute myocardial infarction. However, it is unclear if GWTG hospitals achieving performance achievement awards provide care that is associated with lower mortality from cardiovascular disease and if there are spillover effects of quality improvement efforts. Heidenreich PA et al. Circulation 2009

Objectives To evaluate whether risk adjusted 30 day survival data received from CMS for HF and AMI show that the process of care for hospitals participating in the GWTG program have better outcomes for HF and AMI than non participating hospitals in GWTG. Heidenreich PA et al. Circulation 2009

Methods Data analyzed from hospitals participating in GWTG- CAD and utilizing the web-based patient management tool for data collection (Outcome Sciences Inc, Cambridge, MA) We compared hospitals enrolled in GWTG and receiving achievement awards for high levels of recommended processes of care with other hospitals using data on risk-adjusted 30-day survival for heart failure and acute myocardial infarction reported by the Center for Medicare and Medicaid Services (CMS). Hospitals were classified by hospital type (acute care vs. critical access-rural), profit status (government, private, non-profit), accreditation (yes/no), and presence of emergency services (yes/no). Heidenreich PA et al. Circulation 2009

Methods: Mortality Risk-adjusted mortality data for 3909 hospitals as reported by CMS on their Hospital Compare website was used. 15 Risk adjusted 30-day mortality rates were reported separately for heart failure and acute myocardial infarction admissions. The risk adjustment algorithm based on demographics, prior and concurrent diagnoses. Heidenreich PA et al. Circulation 2009

Methods: Performance Measures Hospital specific process of care data from April 2005 to March 2006 reported by CMS was used. There were 3873 of 3909 hospitals (99%) that reported data (either a complete or a random sample) for at least one quality measure. Hospitals reported on up to eight measures for acute myocardial infarction, four for heart failure, six for pneumonia and two for surgery. The performance measures are reported by hospitals based on specific criteria for eligibility that excludes patients with contraindications. Heidenreich PA et al.; Circulation 2009

Methods: Cardiac Measures The heart failure measures include the following: 1) Assessment of left ventricular function 2) Use of angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker for left ventricular systolic dysfunction (defined as an ejection fraction < 40%) 3) Provision of discharge Instructions 4) Counseling for smoking cessation Heidenreich PA et al Circulation 2009

Methods: Cardiac Measures The acute myocardial infarction measures include 1) use of aspirin at arrival 2) use of aspirin at discharge 3) use of ACE inhibitor or angiotensin receptor blocker for left ventricular systolic dysfunction 4) use of beta-blockers at arrival 5) use of beta-blockers at discharge 6) thrombolytic medication within 30 minutes Of arrival for those treated with thrombolytics for ST elevation myocardial infarction 7) percutaneous coronary intervention within 120 minutes of arrival for those ST elevation myocardial infarction not receiving thrombolytics 8) counseling for smoking cessation Heidenreich PA et al; Circulation 2009

Methods: Non-Cardiac Measures The pneumonia measures include: 1) a blood culture performed prior to first antibiotic received in hospital 2) use of the most appropriate initial antibiotic(s) 3) oxygenation assessment 4) use of pneumococcal vaccination 5) use of initial antibiotic(s) within 4 hours after arrival 6) smoking cessation counseling Heidenreich PA et al; Circulation 2009

Methods: Non-Cardiac Measures The surgical infection prevention measures include the following: 1) Use a preventative antibiotic(s) one hour before incision 2) Discontinuation of the preventive antibiotic(s) within 24 hours after surgery. For categories of measures that showed inconsistent results between award and non award hospitals (pneumonia and surgery) composite measures were created by averaging results for hospitals reporting on each measure in the category. Heidenreich PA et al; Circulation 2009

Results The Guideline Achievement Awards Among the 3909 hospitals with 30-day data reported by CMS 355 (9%) received achievement awards. Fifteen hospitals received awards for all three disease modules (stroke, heart failure and coronary disease), two or more awards were received by 58 hospitals, and 282 hospitals received one award. Awards were provided to 201 hospitals for stroke, 151 for coronary disease and 91 for heart failure care. Heidenreich PA et al. Circulation 2009

Results Hospital Characteristics Hospitals receiving any award were more likely to be acute care hospitals (99% acute care, 1% critical access/rural) vs. non-award hospitals (82% acute care, 8% critical access hospitals, P<0.0001). Hospital accreditation was reported for award hospitals in 98% compared to 79% for non-award hospitals (p<0.0001). Emergency care services were common for both award (97%) and non-award hospitals (95%, p=0.04). Mean income in the counties of hospitals with awards was higher than for those hospitals without awards ($39,500 vs. $32,700, p<0.0001). The location of award hospitals also varied significantly by census division (p<0.0001). (19% of hospitals in the New England division received GWTG achievement awards vs. 4% for the West North Central division). Heidenreich PA et al; Circulation 2009

Results Mortality Thirty day risk-adjusted mortality was 11.2% following admission for heart failure, and 16.4% following admission for an acute myocardial infarction. Risk-adjusted mortality for hospitals receiving GWTG achievement awards was lower for both heart failure (11.0% vs. 11.2%, p=0.0005) and acute myocardial infarction (16.1% vs. 16.5%, p<0.0001) compared to those not receiving awards. Trends toward better survival were observed for all award types and were significant for coronary artery disease and stroke award hospitals. Heidenreich PA et al; Circulation 2009

Results Mortality Adjusted for Hospital Characteristics All baseline models are adjusted for patient characteristics. After additional adjustment for hospital characteristics the decrease in mortality at 30 days associated with award hospitals remained but was no longer significant for heart failure (-0.11%, p=0.11) but remained significant for acute myocardial infarction (-0.18%, p=0.01). Adjustment for non-cardiac performance (pneumonia and surgical measures) had no clear effect as the 30 day mortality reduction remained at -0.11% (p=0.10) for heart failure and increased slightly to -0.19% (p=0.009) for acute myocardial infarction. Heidenreich PA et al; Circulation 2009

Results Mortality Adjusted for Process of Care Measures To assess whether higher performance on process of care measures in award hospitals accounted for the lower 30 day risk adjusted mortality rates observed, mortality rates were further adjusted for these measures. When adjustments for heart failure and acute myocardial infarction process of care were included, the mortality reduction associated with an award dropped by 28% for heart failure (to %, p=0.26) and by 43% for acute MI (to %, p=0.28) and was no longer statistically significant. Heidenreich PA et al; Circulation 2009

Limitations Study was not a randomized trial and analysis was only limited to publicly available data. CMS data on mortality and process of care for stroke was not available. CMS data are limited primarily to those 65 years of age and older, thus, a process-outcome link for younger patients could not be evaluated. Could not determine what part or parts of the GWTG program have the greatest impact on both process of care and mortality. Data for multiple time points were not available so a before-after effect of enrollment in the GWTG program could not be determined. Could not determine the type and value (cost to achieve the small mortality benefit) of any particular intervention the award hospitals may have implemented. Future studies should examine different thresholds or composite measures to determine the metric most associated with outcome. Heidenreich PA et al. Circulation 2009

Conclusions Heidenreich PA et al. Circulation 2009 The findings suggest that hospitals receiving performance achievement awards from the GWTG program had better process of care and risk adjusted 30-day mortality for heart failure and coronary artery disease. While hospital characteristics explained some of this reduction in mortality, improved process of care was also an important factor, particularly for acute myocardial infarction hospitalization. The study provides evidence that quality improvement programs that improve process of care for heart disease may also improve patient outcome.

Clinical Implications Widespread application of GWTG could positively impact the process of care and risk adjusted 30-day mortality for heart failure and coronary artery disease. While hospital characteristics explained some of this reduction in mortality, improved process of care was also an important factor, particularly for acute myocardial infarction hospitalization. This study provides evidence that quality improvement programs that improve process of care for heart disease may also improve patient outcome. Heidenreich PA et al. Circulation 2009